Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  711 results for ""Antirheumatic Agents""

Your Filters

Geographic : japan
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Up to 3-year results from a postmarketing surveillance study.

  • Authors : Kameda H; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University (Ohashi Medical Center), Tokyo, Japan.; Nishida K

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Certolizumab Pegol*/Certolizumab Pegol*/Certolizumab Pegol*/therapeutic use ; Certolizumab Pegol*/Certolizumab Pegol*/Certolizumab Pegol*/adverse effects

  • Source: Modern rheumatology [Mod Rheumatol] 2024 Oct 15; Vol. 34 (6), pp. 1103-1114.Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Evaluation of medication withdrawal in patients with non-systemic juvenile idiopathic arthritis in Japan using a web-based survey.

  • Authors : Ebato T; Department of Pediatrics, Kitasato University, Kanagawa, Japan.; Kishi T

Subjects: Arthritis, Juvenile*/Arthritis, Juvenile*/Arthritis, Juvenile*/drug therapy ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects

  • Source: Modern rheumatology [Mod Rheumatol] 2024 Oct 15; Vol. 34 (6), pp. 1231-1237.Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of safety and effectiveness between etanercept biosimilar LBEC0101 and reference in patients with rheumatoid arthritis in real-world data using the KURAMA cohort.

  • Authors : Kawakami T; Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan.; Masui S

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/blood ; Etanercept*/Etanercept*/Etanercept*/therapeutic use

  • Source: Modern rheumatology [Mod Rheumatol] 2024 Oct 15; Vol. 34 (6), pp. 1135-1141.Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis.

  • Authors : Nakayama Y; Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Nagata W

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Practice Guidelines as Topic*

  • Source: Modern rheumatology [Mod Rheumatol] 2024 Oct 15; Vol. 34 (6), pp. 1079-1094.Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Biologic and targeted synthetic disease-modifying anti-rheumatic drugs improve body composition in rheumatoid arthritis patients more than conventional synthetic disease-modifying anti-rheumatic drugs: Results from the PRESENT study.

  • Authors : Tada M; Department of Orthopaedic Surgery, Osaka City General Hospital, Osaka, Japan.; Matsumoto Y

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/physiopathology ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/diagnosis

  • Source: International journal of rheumatic diseases [Int J Rheum Dis] 2024 Oct; Vol. 27 (10), pp. e15371.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Safety and effectiveness of peficitinib 100 mg/day in patients achieving clinical remission from a long-term open-label extension study in Japan, Korea, and Taiwan (RAJ2).

  • Authors : Tanaka Y; The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Japan.; Takeuchi T

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects

  • Source: Modern rheumatology [Mod Rheumatol] 2024 Aug 20; Vol. 34 (5), pp. 918-926.Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Healthcare resource utilisation and economic burden of patients with adequate and inadequate responses to biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis in Japan.

  • Authors : Ikeda K; Department of Rheumatology, Dokkyo Medical University, Tochigi, Japan.; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/economics ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use

  • Source: Modern rheumatology [Mod Rheumatol] 2024 Aug 20; Vol. 34 (5), pp. 910-917.Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Evaluation of the Rheumatoid Arthritis Observation of Biologic Therapy risk score in Japanese patients with rheumatoid arthritis starting first biologic disease-modifying antirheumatic drugs: A validation study using the Institute of Rheumatology, Rheumatoid Arthritis cohort data.

  • Authors : Higuchi T; Division of Rheumatology, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.; Division of Multidisciplinary Management of Rheumatic Diseases, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use; Humans

  • Source: Modern rheumatology [Mod Rheumatol] 2024 Jul 06; Vol. 34 (4), pp. 693-699.Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Incidence of serious infections in the working-age Japanese adult population with rheumatoid arthritis treated with tumor necrosis factor-α inhibitors and interleukin-6 inhibitors: A nationwide retrospective cohort study.

  • Authors : Ota R; Department of Pharmacy, Kindai University Nara Hospital, Ikoma, Nara, Japan.; Hirata A

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Interleukin-6*/Interleukin-6*/Interleukin-6*/antagonists & inhibitors ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects

  • Source: Pharmacotherapy [Pharmacotherapy] 2024 Jul; Vol. 44 (7), pp. 570-580. Date of Electronic Publication: 2024 Jun 12.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study.

  • Authors : Watanabe R; Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.; Ebina K

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Janus Kinase Inhibitors*/Janus Kinase Inhibitors*/Janus Kinase Inhibitors*/therapeutic use

  • Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 Sep 01; Vol. 63 (9), pp. 2418-2426.Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  711 results for ""Antirheumatic Agents""